Nocturnal Increase in Plasma cGMP Levels in Humans

The circadian dynamics of responses to cyclic guanosine 3’,5’-monophosphate (cGMP) in in vitro experiments and the stimulating effects of the pineal hormone melatonin on cGMP levels both in vitro and in vivo provoked an investigation into the diurnal pattern of occurrence of this second messenger in...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biological rhythms 1999-08, Vol.14 (4), p.307-313
Main Authors: Zhdanova, Irina V., Simmons, Michael, Marcus, Jacob N., Busza, Ania C., Leclair, Ojingwa U., Taylor, Judy A.
Format: Article
Language:English
Subjects:
Area Under Curve
Circadian rhythm
Circadian Rhythm - physiology
Cyclic GMP - blood
Female
Hormones
Humans
Male
Melatonin - physiology
Middle Aged
Sleep
Sleep - physiology
Wakefulness - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The circadian dynamics of responses to cyclic guanosine 3’,5’-monophosphate (cGMP) in in vitro experiments and the stimulating effects of the pineal hormone melatonin on cGMP levels both in vitro and in vivo provoked an investigation into the diurnal pattern of occurrence of this second messenger in human plasma and its correlation with plasma melatonin levels. Plasma cGMP levels were measured in 9 normal human subjects who were over 50 years of age. Samples were obtained hourly through a 20-h period (11 a.m. to 7 a.m.) that included the subjects' habitual hours of nocturnal sleep; physical activity was kept to a minimum during the daylight hours. The area under the timeplasma cGMP concentration curve showed a significant increase during the period of nocturnal sleep compared to that observed during the period of daytime wakefulness. The individual temporal pattern of the nocturnal rise in plasma cGMP differed among the subjects; however, the initial increase typically was observed soon after bedtime. No significant correlation was observed between individual nocturnal plasma melatonin levels and cGMP levels.
ISSN:0748-7304
1552-4531
DOI:10.1177/074873099129000722